EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:59255 - (R)-betaxolol hydrochloride
| Formula | C18H30NO3.Cl |
| Net Charge | 0 |
| Average Mass | 343.895 |
| Monoisotopic Mass | 343.19142 |
| SMILES | CC(C)[NH2+]C[C@@H](O)COc1ccc(CCOCC2CC2)cc1.[Cl-] |
| InChI | InChI=1S/C18H29NO3.ClH/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16;/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3;1H/t17-;/m1./s1 |
| InChIKey | CHDPSNLJFOQTRK-UNTBIKODSA-N |
| Roles Classification |
|---|
| Biological Role: | beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| Applications: | antiglaucoma drug Any drug which can be used to prevent or alleviate glaucoma, a disease in which the optic nerve is damaged, resulting in progressive, irreversible loss of vision. It is often, though not always, associated with increased pressure of the fluid in the eye. beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| (R)-betaxolol hydrochloride (CHEBI:59255) is a betaxolol hydrochloride (CHEBI:643228) |
| (R)-betaxolol hydrochloride (CHEBI:59255) is enantiomer of (S)-betaxolol hydrochloride (CHEBI:59256) |
| Incoming Relation(s) |
| (S)-betaxolol hydrochloride (CHEBI:59256) is enantiomer of (R)-betaxolol hydrochloride (CHEBI:59255) |
| IUPAC Name |
|---|
| (2R)-1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-(propan-2-ylamino)propan-2-ol hydrochloride |
| Synonyms | Source |
|---|---|
| (2R)-3-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-2-hydroxy-N-(propan-2-yl)propan-1-aminium chloride | IUPAC |
| (R)-betaxolol HCl | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| DB00195 | DrugBank |